Clinical Trials Browser

Phase 3 × Enrolling by invitation × Cytarabine × Clear all

NCT03507842 2025-03-17

A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.

Phase 3 Enrolling by invitation

Other hematologic neoplasm

Leukemia, Myeloid, Acute